Wedbush Reiterates Outperform on Tyra Biosciences, Maintains $28 Price Target
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst Robert Driscoll has reiterated an Outperform rating on Tyra Biosciences (NASDAQ:TYRA) and maintained a $28 price target.
August 08, 2024 | 1:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wedbush analyst Robert Driscoll has reiterated an Outperform rating on Tyra Biosciences and maintained a $28 price target.
The reiteration of an Outperform rating and a maintained price target of $28 by a reputable analyst can boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100